Success Story: EB-2 NIW (National Interest Waiver) Approval for Postdoc Researcher of Cancer Biology

Recently, we at Chen Immigration Law Associates received another EB-2 NIW (National Interest Waiver) for Postdoc Researcher working in the field of Cancer Biology. (Approval Notice)

General Field: Cancer Biology
Position at the Time of Case Filing: Researcher
National Origin: Taiwan
Service Center: Nebraska
Processing Time: 113 days

Case Summary:

When approaching NIW (National Interest Waiver) petitions, it is crucial that significant evidence is established in order to offer the client the best possible chance for a fast approval. We at Chen Immigration Law Associates have developed strategies to procure the most substantial evidence required for the approval of these petitions.

With this in consideration, it was vital to this petition to reinforce the substantial and influential contributions this client had made to the specialized field of cancer biology. As this client had achieved notable qualifications including, a PhD in Cancer Biology, and a Medical Degree from a top-tier university in Taiwan, her value could be showcased by her immense aptitude for these fields. Beyond this extraordinary proficiency, this client had published seven articles and abstracts in leading peer-reviewed journal publications, which had been cited at least 34 times.

In addition to the evidence surrounding these important qualifications, we at Chen Immigration Law Associates highlighted the substantial intrinsic merit associated with this client’s employment. As she had conducted the majority of her research in the field of Cancer Biology, this research had facilitated critical advancements to the fundamental science of cancer biology, including an enhanced molecular understanding of the improvement of therapeutic interventions for an array of detrimental health conditions. As these improvements have aided the field of cancer biology towards the developments of new and innovative treatments and therapies for metastatic cancer, bacterial infections, and congenital heart defects, these developments have given merit to the substantial intrinsic value associated with this client’s ongoing research.

With consideration to the mortality rates associated with cancer, the continual research performed by innovative minds offers the national scope significant benefits. Specifically, as this client had distinguished herself as a leading researcher in this field, we at Chen Immigration Law Associates set to reinforce these contributions by citing experts in similar fields of endeavor. In order to assist in this matter and offer the best possible support, we at Chen Immigration Law Associates drafted six letters for the client’s recommenders to review, edit, and sign. These letters provided significant testimony of: (1) the merit associated with this client’s ongoing research; (2) the national scope and importance of these developments within the United States and; (3) the potential adverse effects if this client were unable to continue her research in Cancer Biology.

Using this unique strategy, while correctly articulating the importance surrounding this client’s valued work towards the national interest, we at Chen Immigration Law Associates were able to secure approval for this petition in less than 4 months.

With this in consideration, it is important to emphasize that the processes and expertise practiced by Chen Immigration Law Associates. Not only do we develop the best possible strategies for each case, but we execute these strategies with the utmost effectiveness!

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.